Skip to content

Neurological Fate, Prematurity and Genetic Susceptibility Factors

GENIMOC : Neurological Fate, Prematurity and Genetic Susceptibility Factors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04298346
Acronym
GENIMOC
Enrollment
27
Registered
2020-03-06
Start date
2020-03-09
Completion date
2022-03-09
Last updated
2023-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility of Cervical Origin, Polymorphism, Restriction Fragment Length, Premature

Brief summary

This study could help identify aggravating or protective genetic polymorphisms associated with cerebral palsy. Populations of premature babies at different risk of cerebral palsy could thus be individualized with an impact on their monitoring and on the pathophysiological understanding of the processes leading to neurological lesions.

Interventions

OTHERno intervention

no intervention

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years

Inclusion criteria

* children born prematurely at term \<34 weeks between 2008 and 2015 * assessed at the age of 2 within the Growing Together Network in Pays de Loire * parental consent for the collection of data from their child and for intraoral sampling for the search for genetic factors.

Exclusion criteria

* children who died after the age of 2 * children who refused and / or whose parents refused to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Identify a polymorphism associated with the risk of developing cerebral palsy at 2 years in a regional population of premature infants of gestational age <34 weeks gestation.2 yearsfrequency of variants within the case and control groups using the statistical criterion level of significance (also called p-value and known by the English word p-value) of 5.10-8

Secondary

MeasureTime frameDescription
Identify a specific polymorphism of certain forms of cerebral palsy2 yearsneurological examination
Develop a prognosis algorithm for the occurrence of cerebral palsy for personalized monitoring in a population at risk.2 yearsneurological examination

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026